Current Events
 |
 |
 |
 |
 |
 |
Core Team
Mitch Sanders, Ph.D.
CEO and Founder
Dr. Sanders founded ECI in 1998. Dr. Sanders is a leader in the field of protein engineering, purification and diagnostic sensor development. Dr. Sanders worked as a Senior Scientist II at Genome Therapeutics in the Pathogen Genetics Program. He holds a Ph.D. in Biomedical Sciences from WP, and completed postdoctoral training at the Whitehead Institute at MIT. Dr. Sanders has dual assistant research professor appointments in the Bioengineering Institute and the Biology and Biotechnology Departments at WPI. He serves on numerous scientific and entrepreneurial boards at local universities. For ECI, Dr. Sanders secured an aggregate $20M in equity, corporate development funding, and SBIR grants.
Geert Cauwenbergh, Ph.D.
Chairman
Dr. Cauwenbergh is the Founder of Phase123, a company that is focused on bringing together investigators and sponsors for drug development and clinical studies. Dr. Cauwenbergh was the Founder and CEO of Barrier Therapeutics, which in 2008 was acquired by Stiefel Laboratories, Inc. the world's largest independent pharmaceutical company specializing in dermatology, for approximately $148 mm. Geert has held various executive positions with Johnson and Johnson, has authored over 100 publications and co-authored several books
Geert received his Ph.D. in Medical Sciences from the Catholic University of Leuven, where he also completed his Masters and undergraduate work.
David A. Fogel, CPA
CFO
David Fogel possesses over 24 years of senior financial management experience in various capacities for a variety of high technology companies, including GSI Lumonics, Lilliputian Systems, Lernout & Hauspie (now Nuance), and Core-M, Inc.
Most recently Mr. Fogel was the CFO of the healthcare IT consulting firm Beacon Partners, and previously was Vice President of Finance and Treasurer at Webgen, Inc. Dave recieved his B.S. in Marketing from Miami University in Oxford, Ohio and an M.B.A. in Finance from the University of Cincinnati.
Engineering and Scientists
Dale Macy
VP of US Operations
Dale is an engineering and production professional with over twenty years of experience in device, development, and machine design in the pharmaceutical and automated pharmacy industries. He is experienced with the complete process of new product creation, from concept, development, and design, through manufacture, installation, and qualification at the production site.
He has brought a number of products to the marketplace and holds a patent for a multi-zoned infra-red/electronic tablet counting device used in the pharmaceutical packaging industry.
Dale has a BSME from UMass Lowell with a machine design focus.
Andrei Rakitin, Ph.D.
Senior Scientist II
Andrei received his BS in Electrical Engineering and his PhD in Mathematics
and Physics from MIPT and Institute of General Physics, USSR Academy of
Sciences. Andrei worked as a senior scientist at the Institute for Semiconductors and headed a research laboratory at the Institute for New Physical and Applied Problems in Kiev, Ukraine. He also received a postdoctoral training at the University of Toronto (Canada) and Brown University (USA). Andrei has extensive experience in biostatistics, stochastic processes, microfluidics, solid electrolytes, nanotechnology, and optoelectronics. He was a recipient of JSPS Fellowship for Foreign Researchers (Japan) and was an Adjunct Professor with the Graduate School of Physics at York University. Andrei was awarded two SBIR grants from the USA Department of Defense and has two patents pending on ultrasensitive DNA detection and pathogen detection.
Courtney Mankus, Ph.D.
Senior Scientist
Courtney received her BA in Biochemistry with a concentration in Ethics and Public Policy in 2004 from Clark University, Worcester, MA. While completing her undergraduate degree she interned with ECI Biotech and worked on the development of colorimetric bacterial sensors. She then obtained her doctoral degree in Biochemistry in 2009 from Boston University School of Medicine, Boston, MA. Her graduate work focused on the expression and role of the P2X7 purinergic receptor in the corneal epithelium and corneal stroma. Courtney has extensive experience in confocal and fluorescent microscopy, cell culture, and both protein and molecular biochemical techniques.
Shelley Dougherty, Ph.D.
Senior Scientist
Shelley received her BS in Chemical Engineering from the University of New Hampshire in 2005 and her Ph.D. in Material Science and Engineering from Worcester Polytechnic Institute in 2009. During graduate school she was an intern with Genzyme’s Drug & Biomaterials group for a year and worked on developing hydrogel formulations to prevent post-operative abdominal adhesions. Her dissertation focused on the fabrication of protein and polymer bio-nanomaterials using template-assisted fabrication methods.
Barbara Yeboah
Scientist
Barbara started working for ECI in 2002 and went on to get her BS in Biotechnology with a concentration in Bio-processing from Worcester Polytechnic Institute, MA. She has worked extensively on assay development and assay optimization using fluorescent and colorimetric sensors. She has experience in bead conjugation for the detection of bacterial proteases in vivo and in vitro. She is currently obtaining her RN degree at Becker College in Worcester, MA.
Lindsay Poland
Scientist
Lindsay received her bachelor’s degree in Biology from the University of Massachusetts Amherst. There her work concentrated on cell death in drosophila as part of the Molecular and Cellular Biology Department. She then went on to receive her Master’s degree in Biomedical Sciences from the University of Massachusetts School of Biomedical Sciences. Her master’s work involved utilizing molecular and cellular approaches to explore the cell cycle in S. pombe. She has worked at ECI for the past four years and has been involved in a number of projects with the company.